CYFIP2 serves as a prognostic biomarker and correlates with tumor immune microenvironment in human cancers

CYFIP2 serves as a prognostic biomarker and correlates with tumor immune microenvironment in human cancers

Abstract Background The mechanisms whereby CYFIP2 acts in tumor development and drives immune infiltration have been poorly explored. Thus, this study aimed to identifying the role of CYFIP2 in tumors and immune response. Methods In this study, we first explored expression patterns, diagnostic role...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Qiliang Peng, Bixin Ren, Kedao Xin, Weihui Liu, Md Shahin Alam, Yinyin Yang, Xuhao Gu, Yaqun Zhu, Ye Tian
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	BMC 2023-09-01
Sraith:	European Journal of Medical Research
Ábhair:	CYFIP2 Immuno-oncology Biomarker Prognosis
Rochtain ar líne:	https://doi.org/10.1186/s40001-023-01366-2

Míreanna comhchosúla

Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia
de réir: Xianhui Peng, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus
de réir: Yinhua Zhang, et al.
Foilsithe / Cruthaithe: (2019-11-01)

The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC
de réir: Tong J, et al.
Foilsithe / Cruthaithe: (2021-10-01)

CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target
de réir: Cong Xiao, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma
de réir: Peipei Zhang, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Identification of CYFIP2 Arg87Cys Ligands via In Silico and In Vitro Approaches
de réir: Ísis Venturi Biembengut, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers
de réir: Ning Wang, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Cyfip1 Regulates SynGAP1 at Hippocampal Synapses
de réir: Abhishek Sahasrabudhe, et al.
Foilsithe / Cruthaithe: (2021-02-01)

CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome
de réir: Barbara eBardoni, et al.
Foilsithe / Cruthaithe: (2014-03-01)

New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes
de réir: Sabiha Abekhoukh, et al.
Foilsithe / Cruthaithe: (2017-04-01)

Analysis and Experimental Validation of Rheumatoid Arthritis Innate Immunity Gene CYFIP2 and Pan-Cancer
de réir: ZhenYu Zhao, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Differential Role of the RAC1-Binding Proteins FAM49b (CYRI-B) and CYFIP1 in Platelets
de réir: Dmitri Sisario, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Enhanced Prefrontal Neuronal Activity and Social Dominance Behavior in Postnatal Forebrain Excitatory Neuron-Specific Cyfip2 Knock-Out Mice
de réir: Yinhua Zhang, et al.
Foilsithe / Cruthaithe: (2020-10-01)

CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification
de réir: Zili Lin, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Smaller Body Size, Early Postnatal Lethality, and Cortical Extracellular Matrix-Related Gene Expression Changes of Cyfip2-Null Embryonic Mice
de réir: Yinhua Zhang, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Overexpression of the autism candidate gene Cyfip1 pathologically enhances olivo-cerebellar signaling in mice
de réir: Silas E. Busch, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Cell-autonomous reduction of CYFIP2 changes dendrite length, dendritic protrusion morphology, and inhibitory synapse density in the hippocampal CA1 pyramidal neurons of 17-month-old mice
de réir: Yoonhee Kim, et al.
Foilsithe / Cruthaithe: (2024-12-01)

CYFIP1 gene expression in umbilical cord blood and its relationship with maternal body mass index
de réir: Mahsa Eskandari, et al.
Foilsithe / Cruthaithe: (2024-03-01)

circCYFIP2 Acts as a Sponge of miR-1205 and Affects the Expression of Its Target Gene E2F1 to Regulate Gastric Cancer Metastasis
de réir: Jing Lin, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Cell-autonomous reduction of CYFIP2 is insufficient to induce Alzheimer's disease-like pathologies in the hippocampal CA1 pyramidal neurons of aged mice
de réir: Ruiying Ma, et al.
Foilsithe / Cruthaithe: (2023-12-01)

ELK3-CYFIP2 axis-mediated actin remodeling modulates metastasis and natural killer cell responses in triple-negative breast cancer
de réir: Seung Hee Choi, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach
de réir: Gillian Murtagh, et al.
Foilsithe / Cruthaithe: (2024-02-01)

A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
de réir: Jeffrey R. Whiteaker, et al.
Foilsithe / Cruthaithe: (2023-05-01)

The role of biomarkers in personalized immunotherapy
de réir: Kamya Sankar, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
de réir: Qiliang Peng, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Characterising CD8+ T cell transcriptomic and clonal consequences of immune checkpoint blockade for the treatment of cancer
de réir: Watson, RA
Foilsithe / Cruthaithe: (2023)

Editorial: Tumor microenvironment complexity and its therapeutic implications
de réir: Denner Santos dos Anjos, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Next generation immuno-oncology tumor profiling using a rapid, non-invasive, computational biophysics biomarker in early-stage breast cancer
de réir: Daniel Cook, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion
de réir: Kulik L, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment
de réir: Emily B. Harrison, et al.
Foilsithe / Cruthaithe: (2018-04-01)

A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
de réir: Diana I. Albu, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Germline genetic host factors as predictive biomarkers in immuno-oncology
de réir: Vylyny Chat, et al.
Foilsithe / Cruthaithe: (2019-09-01)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
de réir: Madyson Colton, et al.
Foilsithe / Cruthaithe: (2020-11-01)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
de réir: Meng-huan Wang, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Immunology of Cell Death in Cancer Immunotherapy
de réir: Lorenzo Galluzzi, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Editorial: Modulation of human immune parameters by anticancer therapies, volume II
de réir: Il-Kang Na, et al.
Foilsithe / Cruthaithe: (2023-07-01)

A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology
de réir: Bian Hu, et al.
Foilsithe / Cruthaithe: (2022-10-01)

The role of LARP1 in communication between ovarian tumours and their immune microenvironment
de réir: Gross, F
Foilsithe / Cruthaithe: (2022)

Inflammatory response-based prognostication and personalized therapy decisions in clear cell renal cell cancer to aid precision oncology
de réir: Weimin Zhong, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Immuno-oncological treatment of Non-Small-Cell Lung Cancer (NSCLC) in advanced stage with Nivolumab
de réir: Fabio Venturella, et al.
Foilsithe / Cruthaithe: (2023-03-01)